Globus Medical (GMED) Tops Q1 EPS by 2c, Raises FY Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. LYB
2. RELIANCE:I
3. OKTA
4. NWG
5. NWG:LN
6. REGN
7. CL
8. RDDT
9. MTDR
10. EL

Go back to Globus Medical (GMED) Tops Q1 EPS by 2c, Raises FY Revenue Guidance

Globus Medical Reports First Quarter 2015 Results

May 5, 2015 4:10 PM EDT

AUDUBON, Pa.--(BUSINESS WIRE)-- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2015.

Worldwide sales increased 15.2% to $131.6 million, or 16.4% on a constant currency basis Net income increased 16.6% to $24.6 million Fully diluted earnings per share (EPS) were $0.26 Non-GAAP Adjusted EBITDA was 35.2% of sales Company increases 2015 guidance for sales to $514 million and EPS to $1.02

David Paul,... More